Clinical Trial Detail
| NCT ID | NCT01723202 |
| Title | Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | National Comprehensive Cancer Network, Manisha Shah, Ohio State University Comprehensive Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult |
CKB BOOST